Skip to main content
Clinical Trials/DRKS00028473
DRKS00028473
Not yet recruiting
Phase 4

Functional outcome and painrelief in patients with osteoarthritis of the knee due to oral intake of UC II (undenaturated collagen Typ II):A multicenter, prospective, randomised, placebo controlled clinical trial - OIUC2

Orthopädie im MediaparkMediaPark Klinik Köln0 sites202 target enrollmentMarch 9, 2022

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
M17.1
Sponsor
Orthopädie im MediaparkMediaPark Klinik Köln
Enrollment
202
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 9, 2022
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Orthopädie im MediaparkMediaPark Klinik Köln

Eligibility Criteria

Inclusion Criteria

  • Sufficiently severe gonarthrosis grade II and III according to the nativradiological criteria according to Kellgren/Lawrence or magnetic resonance imaging criteria according to Outerbridge.
  • Diagnosis confirmed by standard X\-ray (AP, lateral, patella tangential, Rosenberg, whole leg) or MRI
  • Age: 50\-70 years
  • Gender: both

Exclusion Criteria

  • Exclusion criteria (knee\-related)
  • \- Arthrofibrosis
  • \- Extension deficit (\<20°)
  • \- Flexion deficit (\> 100°)
  • \- Insufficiency of the anterior and/or posterior cruciate ligament
  • \- Intra\-articular injections with corticosteroid, hyaluronic acid and PRP in the last 3 months
  • \- Chronic use of medication with effect on the joint (e.g. corticoid)
  • Exclusion criteria (not knee related)
  • \- Insufficient German language skills
  • \- Immunological diseases / autoimmune diseases / rheumatic disease

Outcomes

Primary Outcomes

Not specified

Similar Trials